
Advos
Advos.io
@advos
18873 articles
Articles

NextPlat Corp Reports Q4 Progress with $2 Million Cost Savings and Healthcare Expansion
NextPlat Corp (NASDAQ: NXPL, NXPLW) has issued a comprehensive shareholder update detailing operational progress and strategic initiatives for the remainder of 2025, with Interim CEO Charles M. Fernandez reporting significant advancements across all business divisions. The company has implemented a comprehensive restructuri...
October 8, 2025Read more

OptimumBank Holdings Reports $3.6M Q2 Earnings, Surpasses $1 Billion in Assets
OptimumBank Holdings Inc. (NYSE American: OPHC) reported second-quarter 2025 earnings of $3.6 million while surpassing the significant milestone of $1 billion in total assets. The Florida-based community bank also revealed that deposits are growing at a double-digit annualized pace, signaling strong financial health and cus...
October 8, 2025Read more

ESGold Corp. Begins On-Site Validation at Colombian Planta Magdalena Project
ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) has initiated on-site validation and due diligence activities at its Planta Magdalena Project in Colombia, marking a significant transition from planning to operational execution. The company's geological and engineering team has arrived in Colombia to conduct comprehensive field asse...
October 8, 2025Read more

Izotropic Corp. Advances Breast CT Technology with Personalized Radiation Dosing and $375K Financing
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) is intensifying its commercialization strategy for breast cancer imaging technology through a combination of new financing and breakthrough innovations in personalized radiation dosing. The medical device company recently secured $375,000 through a non-brokered private placement to ...
October 8, 2025Read more

TransCode Therapeutics Acquires Polynoma, Secures $25 Million Investment to Advance Oncology Pipeline
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) has entered into a definitive agreement to acquire Polynoma LLC, a privately held immuno-oncology company developing seviprotimut-L, a late-stage polyvalent shed antigen vaccine for the adjuvant treatment of stage IIB and IIC melanoma. Concurrent with the acquisition, TransCode se...
October 8, 2025Read more

Forward Industries Launches Zero-Commission Solana Validator on DoubleZero Network
Forward Industries has launched an institutional-grade validator node on the Solana blockchain, powered by DoubleZero's high-performance global network for distributed systems. The validator operates at 0% commission, allowing users to stake at no cost while supporting the company's transition from capital provider to activ...
October 8, 2025Read more

Quantum BioPharma Launches $7 Million Whistleblower Program Targeting Stock Manipulation
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) has launched a significant whistleblower reward program that offers cash rewards of up to $7 million for verifiable evidence of stock manipulation involving the company's shares. This initiative represents one of the largest corporate whistleblower programs in the biopharmac...
October 8, 2025Read more

Railtown AI Technologies to Acquire AI Partnerships Corp., Creating Canada's First AI Affiliate Marketplace
Railtown AI Technologies Inc. has entered into an amalgamation agreement to acquire all issued and outstanding shares of AI Partnerships Corp. through a three-cornered amalgamation, making AIP a wholly owned subsidiary of Railtown. The transaction involves the issuance of 40 million shares at a deemed price of $0.50 per sha...
October 8, 2025Read more

Ocumetics Reports Promising Early Results for Accommodating Intraocular Lens
Ocumetics Technology Corp. has reported encouraging one-month safety and vision performance results for the first patients receiving the company's Ocumetics Accommodating Intraocular Lens in clinical trials. The early outcomes demonstrate promising safety profiles and visual performance that could represent a significant ad...
October 8, 2025Read more

Oncotelic's Injectable Everolimus Shows Promise in Boosting Drug Bioavailability for Breast Cancer Treatment
Oncotelic Therapeutics Inc. has received clearance to begin Phase 1 clinical trials for Sapu003, an injectable formulation of Everolimus (marketed as Afinitor) that could revolutionize breast cancer treatment by significantly improving drug bioavailability. The development represents a potential breakthrough in oncology the...
October 8, 2025Read more

Izotropic Corporation Highlights Critical Need for Advanced 3D Breast Imaging Technology
During Breast Cancer Awareness Month, Izotropic Corporation emphasized the critical limitations of current breast cancer imaging technologies and the substantial market opportunity for its developing IzoView Breast CT Imaging System. With more than 2.3 million new breast cancer cases reported globally each year and over 315...
October 8, 2025Read more

Oncotelic Therapeutics Announces Phase 1 Trial Enrollment for Novel Intravenous Everolimus Formulation in Australia
Oncotelic Therapeutics, through its joint venture GMP Biotechnology Ltd. with Dragon Overseas Capital Ltd., has announced that patient enrollment is now open for a Phase 1 clinical trial of Sapu-003, a novel intravenous Deciparticle formulation of everolimus. The trial represents the first clinical investigation of an intra...
October 8, 2025Read more

Gold Producers with Strong Cash Flow Positioned as Market Leaders Amid Economic Uncertainty
Gold prices continue to reach unprecedented levels, with spot gold recently trading above $3,800 per ounce as markets anticipate further Federal Reserve rate cuts and continued U.S. dollar weakness. This economic environment, characterized by easing real rates and a global shift toward scarce, nonsovereign assets, has creat...
October 8, 2025Read more

Ohio State Researchers Identify Key Mechanism Behind Cancer Immunotherapy Failures
A new study from Ohio State University Wexner Medical Center has revealed why cancer immunotherapy fails in 60-80% of patients, identifying a previously unknown stress pathway that cripples immune cells' ability to attack tumors. The research discovered the TexPSR pathway, which floods weakened immune cells with misfolded p...
October 8, 2025Read more

Nutriband to Present at Emerging Growth Conference Amid Development of Abuse-Deterrent Fentanyl Patch
Nutriband Inc. (NASDAQ: NTRB) announced that Chairman Serguei Melnik will present at Noble Capital Markets' Emerging Growth Virtual Equity Conference on Wednesday, October 8, 2025, at 3 p.m. ET. The presentation will feature a fireside Q&A session with questions from the live virtual audience, and registered investors can s...
October 8, 2025Read more

Newton Golf Company's Quality Equipment Standards Drive Performance Improvements for Golfers
Newton Golf Company (NASDAQ: NWTG) has established itself as a significant force in the golf equipment market through its dedication to quality and innovation. The company's approach to equipment design emphasizes how proper club selection can dramatically influence a golfer's performance, with their product offerings inclu...
October 8, 2025Read more

Trilogy Metals Stock Surges Over 200% Following Trump Administration Investment and Ambler Road Executive Order
Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) experienced a dramatic stock surge of more than 200% following two significant developments from the Trump administration that signal a major policy shift in domestic mineral development. The administration purchased a 10% equity stake in the company valued at $35.6 millio...
October 8, 2025Read more

Datavault AI Launches Four Digital Asset Exchanges to Capitalize on Quantum Computing Era
Datavault AI Inc. (NASDAQ: DVLT) has announced the formation of four Delaware corporations that will operate as specialized digital asset exchanges, positioning the company for what management describes as quantum-era growth. The newly established exchanges include the International Elements Exchange, International NIL Exch...
October 8, 2025Read more

GlobalTech President Outlines AI and Big Data Strategy in TechMediaWire Podcast Appearance
GlobalTech Corporation President Frank R. Parrish III recently appeared on The TechMediaWire Podcast produced by IBN, where he detailed the technology holding company's approach to creating value through artificial intelligence and big data innovation. During the interview, Parrish explained GlobalTech's dual-vertical strat...
October 8, 2025Read more

Critical Infrastructure Technologies Selected for Team Defence Australia Delegation at Major U.S. Defense Event
Critical Infrastructure Technologies Ltd. (CSE: CTTT) has been selected to participate in the Team Defence Australia industry delegation for the Association of the United States Army Annual Meeting and Exposition 2025, scheduled for October 13-15 at the Walter E. Washington Convention Center in Washington, D.C. This selecti...
October 8, 2025Read more

Numa Numa Resources Positions for Bougainville Mining Revival Amid Global Copper and Gold Demand
Numa Numa Resources Inc. has secured agreements with landowners to develop the Panguna Mine in Bougainville, which contains an estimated $100 billion in copper and gold reserves based on current market prices. The company's business strategy supports but does not depend on Bougainville's independence, positioning it to navi...
October 8, 2025Read more

